Song Su
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
- Photoacoustic and Ultrasonic Imaging
Papers in
- Surgery 23
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
- Pediatric Hepatobiliary Diseases and Treatments 4
-
- Gallbladder and Bile Duct Disorders 8
- Ferroptosis and cancer prognosis 4
- Biliary and Gastrointestinal Fistulas 3
- Co-authors
- Cheng Fang (17 shared papers)Pan He (8 shared papers)Xianming Xia (7 shared papers)Jie Tian (7 shared papers)Zhenhua Hu (2 shared papers)Bo Li (3 shared papers)Zeyu Zhang (3 shared papers)Chongwei Chi (2 shared papers)
- Journals
- Photodiagnosis and Photodynamic Therapy (8 papers)Frontiers in Oncology (6 papers)Frontiers in Genetics (2 papers)BJS Open (2 papers)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Song Su
63 papers receiving 1.6k citations
Song Su's Hit Papers
Peers
Comparison fields: 5 of 107
- Hepatology 126
- Biomedical Engineering 726
- Materials Chemistry 428
- Pulmonary and Respiratory Medicine 222
- Biophysics 40
Countries citing papers authored by Song Su
This map shows the geographic impact of Song Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Song Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Song Su more than expected).
Fields of papers citing papers by Song Su
This network shows the impact of papers produced by Song Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Song Su. The network helps show where Song Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Song Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows Hit paper breakdown → | 2019 | 904 |
| 2 | 2016 | 64 | |
| 3 | 2021 | 48 | |
| 4 | 2020 | 47 | |
| 5 | 2018 | 27 | |
| 6 | 2019 | 25 | |
| 7 | 2025 | 25 | |
| 8 | 2021 | 21 | |
| 9 | 2022 | 21 | |
| 10 | 2022 | 20 | |
| 11 | 2020 | 19 | |
| 12 | 2019 | 18 | |
| 13 | 2022 | 17 | |
| 14 | 2019 | 17 | |
| 15 | 2019 | 17 | |
| 16 | 2021 | 16 | |
| 17 | 2019 | 15 | |
| 18 | 2020 | 15 | |
| 19 | 2015 | 15 | |
| 20 | 2022 | 13 |
About Song Su
Song Su is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Hepatology, Oncology and Molecular Biology, having authored 66 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Gallbladder and Bile Duct Disorders (8 papers), Pancreatic and Hepatic Oncology Research (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Ferroptosis and cancer prognosis (4 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Biliary and Gastrointestinal Fistulas (3 papers). The work is most often cited by research in Hepatology (126 citations), Biomedical Engineering (726 citations), Materials Chemistry (428 citations), Pulmonary and Respiratory Medicine (222 citations) and Biophysics (40 citations). Song Su has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Cheng Fang, Pan He, Xianming Xia, Jie Tian, Zhenhua Hu, Bo Li, Zeyu Zhang, Chongwei Chi, Yuanxue Zhang and Zhen Cheng. Their work appears in journals such as Photodiagnosis and Photodynamic Therapy, Frontiers in Oncology, Frontiers in Genetics, BJS Open and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.